Literature DB >> 1600843

Effects of repeated ivermectin treatment in onchocerciasis.

F L Njoo1, J S Stilma, A van der Lelij.   

Abstract

A group of 87 onchocerciasis patients from a hyperendemic area without vector control was treated with a single dose of 150 micrograms/kg ivermectin. A second, third and fourth dose was administered 5, 12 and 17 months later to 44, 35 and 25 patients. Skin snip loads reduced substantially following each consecutive dose. However, after three doses 44% of the patients remained skin snip positive. Side-effects decreased from 32.2% requiring medical treatment at the first dose to none after the fourth dose. From this study it was concluded that a complete eradication of microfilariae in skin snips in severely infected persons living in a hyperendemic area without vector control is probably not feasible. Medical supervision for the observation of side-effects after the third dose can be limited.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600843     DOI: 10.1007/bf00158256

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Authors:  A Van der Lelij; A Rothova; N Klaassen-Broekema; W R Wilson; R F Barbe; J S Stilma
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

2.  Ocular and systemic side effects following ivermectin treatment in onchocerciasis patients from Sierra Leone.

Authors:  J S Stilma; A Rothova; G van der Lelij; W R Wilson; R F Barbe
Journal:  Acta Leiden       Date:  1990

3.  A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.

Authors:  B M Greene; Z D Dukuly; B Muñoz; A T White; M Pacqué; H R Taylor
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

4.  The effects of ivermectin on transmission of Onchocerca volvulus.

Authors:  E W Cupp; M J Bernardo; A E Kiszewski; R C Collins; H R Taylor; M A Aziz; B M Greene
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

5.  Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.

Authors:  A T White; H S Newland; H R Taylor; K D Erttmann; E Keyvan-Larijani; A Nara; M A Aziz; S A D'Anna; P N Williams; B M Greene
Journal:  J Infect Dis       Date:  1987-09       Impact factor: 5.226

6.  Side-effects of ivermectin in treatment of onchocerciasis.

Authors:  A Rothova; A van der Lelij; J S Stilma; W R Wilson; R F Barbe
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

7.  Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

Authors:  B M Greene; H R Taylor; E W Cupp; R P Murphy; A T White; M A Aziz; H Schulz-Key; S A D'Anna; H S Newland; L P Goldschmidt
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

8.  Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin.

Authors:  A Rothova; A Van der Lelij; J S Stilma; N Klaassen-Broekema; W R Wilson; R F Barbe
Journal:  Am J Ophthalmol       Date:  1990-07-15       Impact factor: 5.258

9.  Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.

Authors:  M Pacqué; B Muñoz; B M Greene; H R Taylor
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

  9 in total
  1 in total

1.  Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.

Authors:  Hudu O Osue
Journal:  Ethiop J Health Sci       Date:  2017-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.